Applied Therapeutics faces challenges after FDA rejection, but future opportunities exist. Learn why APLT stock could recover ...

The Food and Drug Administration approved on Friday a new medicine from ... will be sold by BridgeBio under the brand name Attruby. The FDA cleared Attruby to treat patients with the heart ...

The FDA has approved a new COVID-19 vaccine, but experts debate the best time to get it. World’s largest piracy network taken ...

With winter setting in around much of the country, many people are also gearing up for cough and cold season. But the Food ...

Novartis NVS announced that the European Commission (“EC”) has approved its breast cancer drug Kisqali (ribociclib) for a ...

Regulatory policies influence the availability of affordable biosimilars, with varying impacts across different jurisdictions ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

A troubling sex trend is making its way across college campuses nationwide, and doctors are concerned. Healthy college men ...

The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.

Virginia should see if other states’ plans to import lower-cost medications from Canada work before asking for federal ...

Is Amazon a stock to buy and hold for decades? I think so. The number of users on Meta's social media platforms continues to ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal ...